Lakeridge Health Oshawa, formerly Oshawa General Hospital, is a hospital located in Oshawa, Ontario, Canada. It was founded in August 1910 in a two-story building, and major additions were made in the 1920s. "G" Wing opened in 1970 on the occasion of the hospital's 60th anniversary.

There are 363 beds in Lakeridge Health Oshawa; Oncology.

During the past decade, Lakeridge Health Oshawa; Oncology conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 21 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 9 clinical trials were completed. i.e. 900% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lakeridge Health Oshawa; Oncology" #1 sponsor was "Hoffmann-La Roche" with 21 trials, followed by "Pfizer" with 4 trials sponsored, "NCIC Clinical Trials Group" with 2 trials sponsored, "Ontario Clinical Oncology Group (OCOG)" with 2 trials sponsored and "Achieve Life Sciences" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lakeridge Health Oshawa; Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Princess Margaret Hospital, Canada" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Lakeridge Health Oshawa; Oncology" are "Bladder Cancer" (4 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Non-Small Cell Lung Cancer" (3 trials) and "Melanoma" (2 trials). Many other conditions were trialed in "Lakeridge Health Oshawa; Oncology" in a lesser frequency.

Most popular intervention types in "Lakeridge Health Oshawa; Oncology" are "Drug" (33 trials), "Other" (5 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (10 trials), "Placebo" (6 trials), "Docetaxel" (4 trials), "Carboplatin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lakeridge Health Oshawa; Oncology" are 32 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Lakeridge Health Oshawa; Oncology". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Lakeridge Health Oshawa; Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lakeridge Health Oshawa; Oncology, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".